Sigachi Industries shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters36.69%no change

Foreign investors (FII)0.52%−0.73 pts

Domestic institutions (DII)0.05%+0.05 pts

of which mutual funds0.00%no change

Public62.74%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SIGACHI₹26.54

Sigachi Industries Limited

· Pharma & Health

₹ CrorePeersLINCOLN THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY NGLFINEMcap ₹1,014 Cr

Holding % of Total Shares 12 Months Ending	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	45.43	44.71	44.71	44.14	44.14	40.48	39.70	36.69	36.69	36.69
FII / FPI	1.56	1.58	0.16	0.08	2.89	3.10	3.33	1.30	1.25	0.52
DII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.05

Latest: 2026-09-30 · 25 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.